Myths vs facts: Homocystein and longevity

Myths vs facts: Homocysteine and longevity. A common myth is that elevated homocysteine directly shortens lifespan and that lowering it will automatically extend life. The evidence is more nuanced: homocysteine is a risk marker for cardiovascular disease, but randomized controlled trials with B vitamins (folate, B12, B6) to lower homocysteine have not shown clear benefits for all-cause mortality. Observational studies consistently link high homocysteine with increased risk of heart attack, stroke, and dementia, but causality remains uncertain. Homocysteine is a byproduct of methionine metabolism and is involved in methylation and oxidative stress—processes tied to aging. However, evidence for a direct longevity benefit from lowering homocysteine is weak. Another myth is that everyone should routinely test their homocysteine. In reality, testing is most useful for individuals with known risk factors (e.g., poor diet, kidney disease, family history of hyperhomocysteinemia). For healthy individuals without risk factors, the value of routine screening is unclear. In summary, homocysteine is a relevant biomarker but not a direct 'longevity switch.' The evidence is moderate, primarily from observational studies.